VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Community Activities
Products
Product Groups
Products A-Z
Investors
IMP stock information
Financial information
Annual Report & Sustainability Development
AGM
Corporate Governance
Information Disclosure
Analyst Report
News - Events
Community
Careers
Media
Contact
Home
Investors
Corporate Governance
IMP stock
information
Financial
information
Annual Report &
Sustainability Development
AGM
Corporate
Governance
Information
Disclosure
Analyst
Report
Investor
Events
Close Filter
Find report
Search
Corporate Governance
IMP - Report on Corporate Governance for 2024
01/23/2025
Download
IMP - Disclosure on the termination of Mephydica as an associate company
11/26/2024
Download
IMP - 10M2024 Business Updates
11/26/2024
Download
IMP - Official letter to HOSE: Adjust the Voting Result Minutes of shareholders' written opinions No. 03/2024/BB-DHDCD-IMP dated October 30, 2024
11/07/2024
Download
IMP - 3Q2024 and 9M2024 Business Results
11/05/2024
Download
IMP - Announcement on the change in personnel of Imexpharm Corporation
10/30/2024
Download
IMP - BOD Resolution No. 17 on dismissal/election of BOD Chairman
10/30/2024
Download
IMP - Resolution of the GMS No. 04 approving the implementation of the Cat Khanh Pharmaceutical Factory Complex Project
10/30/2024
Download
1
2
3
4
5
6
7
8
9
10
20
›
»
Corporate Governance
Our Charter
Corporate Governance Reports
Prospectus